Anne Gulland. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Amphotericin B/economicsAmphotericin B/therapeutic useAntiprotozoal Agents/economicsAntiprotozoal Agents/therapeutic useDisease OutbreaksDrug CostsHumansLeishmaniasis, Visceral/drug therapyLeishmaniasis, Visceral/economicsLeishmaniasis, Visceral/epidemiologySudan/epidemiology
Substances: See more » Antiprotozoal Agentsliposomal amphotericin BAmphotericin B
Year: 2002 PMID: 12433757 PMCID: PMC1124632 DOI: 10.1136/bmj.325.7373.1133/b
Source DB: PubMed Journal: BMJ ISSN: 0959-8138